An update on the EMCDDA 2008 Selected Issue on drug-related research, this thematic paper identifies current and future challenges and opportunities for drug-related research in Europe.
The National Centre in HIV Social Research and the Aboriginal Health and Medical Research Council of NSW announce the release of a jointly produced research brief: Injecting drug use among Aboriginal people in NSW.
The first annual review of the Drug Strategy 2010 - ‘Reducing demand, restricting supply, building recovery: supporting people to live a drug-free life’, has been released by the Home Office.
A report published by the NTA estimates that current drug treatment provision prevents 4.9 million crimes in England a year, with an estimated saving to society of £960 million in costs to the public, business, the criminal justice system and the NHS.
The Obama administration deserves credit for at least acknowledging the wasteful excesses of domestic drug enforcement and for taking steps to bolster treatment. But talk of a revolution in U.S. drug policy is still premature.
EHRN's report assesses the consequences of the sharp reduction in donor support that forced The Global Fund to halt new funding and to impose cost-cutting measures.
This report describes the illicit trade of opiates along the Northern route from northern
Afghanistan to Central Asia up to the borders of the Russian Federation.
Naloxone should be made more widely available to tackle the high numbers of fatal opioid overdoses in the UK, according to a new report by the Advisory Council on the Misuse of Drugs (ACMD).
This report provides general conceptions of the global security challenges posed by violent armed groups; identifies the issues of greatest import to scholars studying the phenomenon; and emphasises the need for the U.S. Government to understand variations in the challenges it faces from enemies.
The report includes a set of recommendations, most prominent of which is a call to the Global Fund to ensure that it continues to support HIV and harm reduction programmes, so that global commitments to reduce HIV transmission of HIV among people who inject drugs by 50% by 2015 can be met.
